Our blood platform comprises of biomarkers that allow comprehensive research into the interplay of health, lifestyle factors, genetics as well as future disease risk. The platform enables simultaneous quantification of numerous groups of biomarkers, for instance, routine lipids, lipoprotein subclass profiling (with lipid concentrations within 14 subclasses), fatty acid composition and various low-molecular metabolites.